Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc.（MRVI）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
mrvi · 股价预测 · 14 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 14 位华尔街分析师
Buy
14 位分析师
共识
评级分布
12 个月目标价
High
$6.00
Consensus
$5.25
+3.3% upside
Low
$4.50
Median: $5.25 · Last Close: $5.08
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$5.25
3.3% upside
High Target
$6
18.1%
Low Target
$4.5
-11.4%
Current Price
$5.08
as of today
Based on analyst price targets, the MRVI stock price prediction for the next 12 months ranges from $4.5 to $6. The consensus MRVI price forecast of $5.25 implies 3.3% upside from the current price of $5.08.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.33 | ↑ 5.00% |
1-day model range: $5.26–$5.4. Peak: $5.4 (+5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $3 | -40.3% |
| 2028 | $2 | -53.5% |
| 2029 | $2 | -59.2% |
| 2030 | $2 | -61.9% |
| 2031 | — | -63.3% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MRVI · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-08 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-12-15 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-08-12 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-08-12 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-05-13 | Baird | Maintains | Neutral→Neutral |
| 2025-05-13 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-03-25 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2025-03-21 | UBS | Maintains | Neutral→Neutral |
| 2025-03-03 | B of A Securities | Maintains | Buy→Buy |
| 2025-02-26 | Baird | Downgrade ↓ | Outperform→Neutral |
Wall Street analysts have recently issued updated ratings on Maravai LifeSciences Holdings, Inc. (MRVI) stock. Of the recent 72 rating actions, 1 were upgrades and 9 were downgrades. 14 analysts currently cover MRVI.
分析师推荐趋势
MRVI analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$210M
↓ 13.5% YoY
Revenue Next Year
$226M
↑ 7.3% YoY
EPS This Year
$-0.11
EPS Next Year
$-0.09
↓ 19.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast MRVI EPS of $-0.11 for the current fiscal year, based on estimates from 5 analysts. The MRVI revenue forecast is $210M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
MRVI 股价预测由两类独立数据源支撑：来自 14 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。MRVI 的共识目标价为 $5.25（+3.3% 上行空间），分析师共识为 Buy。
MRVI 的短期预测（明日）为 $5.33（+5.00%）。 MRVI 对 2027 年的股价预测均值为 $3。 MRVI 对 2030 年的预测区间为 $2–$2。
Maravai LifeSciences Holdings, Inc. 在 NASDAQ 上市，代码 MRVI。MRVI 在 2027 年的整体展望偏积极，在覆盖分析师中约 50% 对应 Buy 共识。
常见问题
MRVI 预测 · 8 个问题根据 14 位华尔街分析师，MRVI 的 12 个月平均目标价为 $5.25，最高 $6.00、最低 $4.50。若有图表，中位目标价可在上方查看。相对当前价 $5.08，隐含约 +3.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.